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Background: Heifers not used as breeding stock are often implanted with steroids to increase growth efficiency
thereby altering hormone profiles and potentially changing the environment in which ovarian follicles develop.
Because bovine granulosa cell culture is a commonly used technique and often bovine ovaries are collected from
abattoirs with no record of implant status, the objective of this study was to determine if the presence of an
implant during bovine granulosa cell development impacts follicle stimulating hormone-regulated steroidogenic
enzyme expression. Paired ovaries were collected from 16 feedlot heifers subjected to 1 of 3 treatments:
non-implanted (n = 5), Revalor 200 for 28 d (n = 5), or Revalor 200 for 84 d (n = 6). Small follicle (1 to 5 mm)
granulosa cells were isolated from each pair and incubated with phosphate buffered saline (n = 16) or 100 ng/mL
follicle stimulating hormone (n = 16) for 24 h.
Results: Granulosa cells of implanted heifers treated with follicle stimulating hormone produced medium
concentrations of progesterone similar (P = 0.22) to non-implanted heifers, while medium estradiol concentrations
were increased (P < 0.10) at 28 and 84 d compared to non-implanted heifers indicating efficacy of treatment.
Additionally, real-time PCR analysis in response to follicle stimulating hormone treatment demonstrated a decrease
in steroidogenic acute regulatory protein (P = 0.05) mRNA expression in heifers implanted for 84 d and an increase
in P450 side chain cleavage mRNA in granulosa cells of heifers implanted for 28 (P < 0.10) or 84 d (P < 0.05)
compared to non-implanted females. However, no difference in expression of 3-beta-hydroxysteroid dehydrogenase
(P = 0.57) and aromatase (P = 0.23) were demonstrated in implanted or non-implanted heifers.
Conclusions: These results indicate follicles which develop in the presence of high concentrations of androgenic
and estrogenic steroids via an implant tend to demonstrate an altered capacity to respond to follicle stimulating
hormone stimulation. Thus, efforts should be made to avoid the use of implanted heifers to study steroidogenesis
in small follicle granulosa cell culture systems.
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Combination trenbolone acetate (TBA) and estradiol-17β
(E2) implants are commonly used in feedlot cattle to in-
crease feed efficiency and muscle mass [1]. However, expos-
ure to exogenous hormones also influences other
physiological functions. SJ Jones, RD Johnson, CR Calkins
and ME Dikeman [2] demonstrated that implanted bulls
had reduced cortisol and testosterone serum concentrations* Correspondence: jah.hernandez_gifford@okstate.edu
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stated.and smaller testicular size compared to non-implanted
bulls. These data indicate that combination implants alter
adrenal and gonadal steroid production and normal go-
nadal development.
In females, elevated concentrations of hormones, includ-
ing estradiol, can alter ovarian function and steroid hor-
mone synthesis. Anabolic agents used to enhance growth
inhibit pituitary release of gonadotropins [3] as a result of
the androgenic activity as exhibited by TBA [4] or the es-
trogenic activity [5]. Consequently, implanting developing
heifers has marked impacts on reproductive function.
Heifers receiving a TBA and E2 implant at 84 d of age hadtd. This is an Open Access article distributed under the terms of the Creative
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opment [6]. Ewes prenatally treated with testosterone dur-
ing mid-gestation did not display a delay in onset of
puberty but demonstrated absent or disrupted progesto-
genic cycles, and had larger follicles with prolonged pres-
ence [7]. Heifers receiving a TBA implant at estrus or d 13
of the estrous cycle were anestrus for a period of time dur-
ing growth promotant release, thereafter d 13 implanted
heifers remained anestrus due to follicle or luteal cysts [8].
Though steroid implants are not intended for use in
breeding females, bovine ovaries are often harvested
from abattoirs for GC culture to investigate mechanisms
regulating follicle maturation and differentiation. To our
knowledge there is no study demonstrating the impact
of elevated levels of androgens and estrogens on the de-
veloping follicle. Therefore, the objective of this study
was to determine if the presence of anabolic and estro-
genic steroids impacts follicle stimulating hormone
(FSH)-regulated steroidogenic enzyme expression.
Methods
Animals
All procedures involving animals were approved by the
Oklahoma State University Institutional Animal Care and
Use Committee (AG-12-4). Sixteen predominantly Angus
heifers (361 kg) were randomly assigned to one of three im-
plant groups: non-implanted (n = 5), implanted for 28 d
with a combination implant (200 mg TBA+ 20 mg E2;
Revalor 200®; Intervet, Inc., Millsboro, DE, USA; 28 d;
n = 5), and 84 d with Revalor 200® (84 d; n = 6). Assigned
heifers were implanted on d 0 (group implanted for 84 d)
or d 56 (group implanted for 28 d) and were not re-
implanted. Heifers were harvested on d 84 and 85 and
paired ovaries were harvested (Robert M. Kerr Food and
Agriculture Products Center, Oklahoma State University,
Stillwater, OK) from each heifer for GC collection and
culture.
Granulosa cell culture
Small follicle (1 to 5 mm) GC were isolated from ovaries of
each animal and each animal’s GC were cultured separately
using methods previously described [9]. Follicle size selec-
tion was based on the intent of investigating FSH signaling
cascades in implanted and non-implanted heifers. Previous
observations indicate that 1) recruitment of bovine follicles
able to respond to FSH occurs at a diameter of 1 to 3 mm
[10]; 2) GC acquire FSH receptors prior to follicular re-
cruitment [11,12]; and 3) GC of recruited follicles express
steroidogenic enzyme mRNAs before LH receptor mRNA
is detected [13]. Briefly, GC were resupended and washed
twice in short-term media (1:1 mixture of Dulbecco’s Modi-
fied Eagle Medium (DMEM) and Ham’s F12 containing
0.12 mmol/L gentamycin and 38.5 mmol/L sodium bicar-
bonate) obtained from Sigma-Aldrich (St. Louis, MO,USA). After the final wash, cells were re-suspended in 0.5
to 2 mL of resuspension medium (serum-free medium with
2.5 mg/mL collagenase and 1 mg/mL DNase) (Sigma-
Aldrich) to prevent cell clumping prior to plating. Cell
number and viability were determined via hemocytometer
using trypan blue dye exclusion. Granulosa cells from each
animal were seeded in two-60-mm culture dishes at a dens-
ity of 5.2 × 105 cells in DMEM complete medium (1:1
DMEM and Ham’s F-12 containing 10% fetal bovine serum,
0.12 mmol/L gentamycin, 2.0 mmol/L glutamine, and
38.5 mmol/L sodium bicarbonate). Incubation of cells oc-
curred at 38.5˚C and 5% CO2 and medium was changed
every 24 h until cell confluency reached 70-75%. Once con-
fluency was reached, medium and unattached cells were re-
moved. To test how each animal’s GC responded to FSH
treatment, one culture dish of GC from each animal were
incubated with phosphate buffered saline (PBS; Con;
n = 16) in serum free media supplemented with 10-7 mol/L
testosterone propionate (Sigma-Aldrich) for 24 h, allowing
each animal to serve as its own control. The second culture
dish was treated with 100 ng/mL purified human FSH
(S1AFP-B-3; National Hormone and Peptide Program, Na-
tional Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, Bethesda, MD,
USA; n = 16) in serum free media supplemented with
10-7 mol/L testosterone propionate (Sigma-Aldrich) for
24 h. Treatment medium was collected and frozen at
−80°C until analysis. Treatments were terminated by re-
moving medium and rinsing cells once with ice cold PBS.
Cells were scraped into 1 mL TRIzol (Invitrogen, Grand
Island, NY, USA) reagent and stored at −80°C until isola-
tion of RNA.
RNA extraction and quantitative real-time PCR
RNA was isolated from cultured GC using TRIzol re-
agent according to the manufacturer’s protocol and
stored at −80°C. Integrity of RNA was assessed by
visualization of 18S and 28S ribosomal RNA resolved
by agarose gel electrophoresis. RNA purity and quan-
tity was determined using a NanoDrop, ND 1000
Spectophometer (Thermo Fisher Scientific, Wilmign-
ton, DE, USA). Purity was determined by 260/280 nm
absorbance ratios, absorbance ratios above 1.8 were
considered acceptable. Total RNA (1 μg) was treated
with 1 μL DNase I Amplification Grade (Invitrogen)
to remove genomic DNA contamination following
manufacturer’s instructions. First strand cDNA was
synthesized from total RNA using oligo(dT) primers
and 1 μL Superscript II Reverse Transcriptase (Invi-
trogen) for each FSH-treated and non-treated sam-
ples. Samples were stored at −20°C until analysis. All
gene specific primers were designed using Primer3
[14] and synthesized by Integrated DNA Technologies
(Coralville, IA, USA). Forward and reverse primer
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dated at a concentration of 300 nmol/L using a 7-log
dilution curve as previously reported [15].
A working solution of cDNA was prepared by dilut-
ing 1:10 with DEPC-treated water. Five microliters of
cDNA working solution was added to 20 μL master
mix containing 13 μL SYBR green and fluorescein
mix (Bioline, Taunton, MA, USA) and 0.75 μL of each
forward primer (10 μmol/L) and reverse primer
(10 μmol/L). Real-time PCR analysis for each sample
was carried out in duplicate using a CFX real-time
PCR detection system (Bio-Rad Laboratories,
Hercules, CA, USA). Standard thermocycler condi-
tions were as follows: 95°C for 10 min, followed by
40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C
for 30 s. Relative fold change in target mRNAs was
quantified using the ΔΔCq method where the FSH
ΔΔCq for each animal was determined by subtracting
each animals Con ΔCq from their FSH ΔCq [16]. All
reverse-transcribed cDNA samples were assayed in
duplicate for each gene, and melt curve analyses were
performed to ensure specificity of amplification. Melt
curve analysis was carried out for 81 cycles with
0.5°C temperature increase from 55°C to 95°C.
To determine the appropriate reference gene to
normalize cDNA variability between samples, a panel
of three reference genes was analyzed including,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
cyclophilin A (PPIA), and mitochondrial ribosomal
protein L19 (MRPL19). The raw Cq values were ob-
tained for each gene in all samples and analyzed
using GeNorm (Biogazell qbasePLUS2, Zwijnaarde,
Belgium) to determine the most stable normalization
factor. The most stable housekeeping gene for target
gene normalization was determined to be GAPDH
and was used as the reference gene [17].Table 1 Primer sequences used in real-time PCR








13β-HSD = 3β-hydroxysteroid dehydrogenase.
2CYP11A1 = P450 side chain cleavage.
3CYP19A1 = aromatase.
4GAPDH = glyceraldehyde-3-phosphate dehydrogenase.
5MRPL19 =mitochondrial ribosomal protein L19.
6PPIA = cyclophilin A.
7STAR = steroidogenic acute regulatory protein.Radioimmunoassay
Granulosa cell culture medium was analyzed for E2 and
progesterone (P4) by solid-phase radioimmunoassay using
components of Siemens Medical Diagnostics Corp (Los
Angeles, CA, USA) commercial kits as previously described
[9]. The E2 concentration in samples of cell culture medium
was determined in 200 μL of medium and the specific bind-
ing was 62.5%. Detection limit (95% of maximum binding)
of the assay was 2 pg/mL. Intra-assay CV for E2 was 6.5%
for cell culture medium. The P4 concentration in samples
of GC medium was assayed at 10 μL. The specific binding
was 58.8%. Detection limit (95% of maximum binding) of
the assay was 0.1 ng/mL. Intra-assay CV for P4 was 4.1%
for cell culture medium.
Statistical analysis
Experiments were analyzed by analysis of variance for a
completely randomized design in which three treatments
were included; non-implanted (n = 5), Revalor 200® for
28 d (n = 5), and Revalor 200® for 84 d (n = 6). Relative
fold changes in gene expression for steroidogenic acute
regulatory protein (STAR), 3β-hydroxysteroid dehydro-
genase (3β-HSD), P450 side chain cleavage (CYP11A1),
and aromatase (CYP19A1) mRNA, and medium hormo-
nal concentration of P4 and E2 are presented as the least
square means ± standard error of the mean. For all cul-
ture experiments, GC from each animal were kept separ-
ate and each animal’s GC were subjected to either
control treatment or FSH treatment. Thus, fold change
values are each animal’s FSH response relative to that
animal’s non-treated controls. A value in CYP11A1
mRNA expression of a non-implanted heifer at least
three standard deviations from the mean and a missing
fold change for CYP19A1 in the 84 d treatment group
were excluded from statistical analysis. Quantitative real-











FSH Effect P < 0.01
Figure 1 Anabolic androgens and estrogens did not affect
progesterone (P4) production but increased estradiol (E2)
concentrations. Small follicle granulosa cells from non-implanted
heifers (n = 5) or heifers implanted for 28 d (n = 5) or 84 d (n = 6)
were treated for 24 h with FSH (100 ng/mL, 24 h) or PBS, subse-
quently cell culture medium were analyzed by RIA. (A) Combination
implants of TBA and E2 did not affect the ability of granulosa cells to
produce P4. (B) Medium E2 concentrations were greater in cells ex-
posed to FSH (P < 0.01) compared to non-treated controls indicating
successful FSH treatment. Additionally, medium E2 concentrations in-
creased (P < 0.10) in granulosa cells from implanted heifers com-
pared with non-implanted. Concentration is presented as the least
square mean ± pooled standard error. Results are compared within
FSH treatment group. *P < 0.10 indicates a significant difference
when compared with non-implanted heifers.
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tute, Cary, NC, USA). Data were tested for homogeneity
of variance using Hartley’s F max test and STAR and E2
were corrected by log transformation (log + 3 and log +
1, respectively). When a significant treatment effect was
observed, means were separated using the least signifi-
cant test computed by the predicted difference option of
SAS. Statistical significance was set at P < 0.10.
Results and discussion
The anabolic effects of implants are likely a consequence
of altering the endogenous hormonal milieu. This con-
cept is supported by the demonstrated increase in
plasma GH concentrations in response to E2 [18] or
TBA and E2 [19] implants. High levels of anabolic hor-
mones can also modulate reproduction as demonstrated
by TBA induced anestrus in cows [8,20] and delayed pu-
berty and decreased fertility in TBA plus E2 implanted
heifers compared to non-implanted controls [6,21].
To determine the steroidogenic capacity of small fol-
licle GC from an environment of elevated anabolic ste-
roids, we first evaluated steroid accumulation in cell
culture medium. Hormonal output was analyzed via
radioimmunoassay. The ability of cultured GC to
synthesize P4 was not affected by heifer implant status
(P = 0.22; Figure 1A). These results are similar to previ-
ous studies in which bovine GC were cultured with
200 ng/mL FSH and also did not show an effect on pro-
duction of P4 in cell culture medium compared to con-
trols [22]. As expected, FSH treated GC had increased
(P < 0.01) concentrations of E2 compared to PBS-treated
controls (Figure 1B) demonstrating successful induction
of the FSH signaling pathway. Additionally, GC from
heifers implanted for 28 d or 84 d produced greater con-
centrations of E2 (78 and 80 ± 21 pg/mL, respectively)
compared to non-implanted heifers (26 ± 21 pg/mL;
P < 0.10; Figure 2B) in response to FSH.
Based on the apparent change in estrogen production
as a result of implant status and that estrogen produc-
tion by the follicle is determined by FSH regulation of
genes encoding key steroidogenic enzymes, we next eval-
uated gene expression of the steroidogenic enzymes of
non-implanted and implanted heifers in response to
FSH. Analysis of steroidogenic enzyme mRNAs of pu-
bertal heifers implanted with TBA and E2 in the pres-
ence or absence of FSH demonstrated differences in
expression as compared to non-implanted heifers. The
first rate limiting step in steroid synthesis is the delivery
of cholesterol to the inner mitochondrial membrane
which is mediated by steroid acute regulatory protein
(STAR). Expression of STAR was reduced (P < 0.05) in
response to FSH in cells from heifers exposed to TBA
and E2 for 84 d when compared to non-implanted
heifers and heifers implanted for 28 d (Figure 2A). STARis fundamental to the biosynthesis of steroid hormones
as it provides cholesterol to the cytochrome P450 side-
chain cleavage enzyme (CYP11A1). Mitochondrial
CYP11A1 catalyzes the cleavage of the cholesterol side
chain to form pregnenolone and this reaction represents
the first committed step in steroidogenesis. Follicle
stimulating hormone increased mRNA expression of
CYP11A1, in GC from 28 d (P < 0.10) and 84 d (P < 0.05)
implanted heifers as compared to non-implanted
(Figure 2B). Studies indicate that both delivery of choles-
terol to the enzyme system and the expression of
CYP11A1 are important factors controlling the rate of




Figure 2 Expression of key steroidogenic enzymes is altered in
FSH stimulated granulosa cells from implanted heifers. Bovine
small follicle granulosa cells were treated as described in Figure 1.
Gene expression data are represented as fold change for each group
compared to its respective control to demonstrate individual group
response to FSH treatment. Fold change of (A) STAR, (B) CYP11A1,
(C) 3βHSD, and (D) CYP19A1 mRNA expression was analyzed by real
time-PCR. Statistical significance is presented as the least square
mean ± pooled standard error. *P < 0.10 and **P < 0.05 indicates a
significant difference when compared with non-implanted heifers.
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84. In the female, ovarian androgens and estrogens regu-
late release of LH and FSH by feedback mechanisms on
the hypothalamus and pituitary and it is not unexpected
that exposure to anabolic steroids may disrupt this deli-
cate balance. Elevated concentrations of anabolic and es-
trogenic steroids from the implants did not have a
marked effect on mRNA expression of 3β-HSD
(P = 0.57; Figure 2C) the enzyme responsible for convert-
ing pregnenolone to progesterone. Next, we evaluated
CYP19A1, the enzyme in granulosa cells responsible for
converting androgens to estrogen. However, no change
in gene expression was detected for CYP19A1 in control
versus heifers implanted for 28 or 84 d (P = 0.22;
Figure 1D). This may be explained in part by the rela-
tively short 3 h half-life of CYP19A1 in FSH-stimulated
bovine granulosa cells compared to the more stable 14 h
half-life demonstrated for CYP11A1 [24].
Additionally, although implant status did not result
in significant changes in CYP19A1 mRNA expression,
E2 concentrations however, were elevated in both FSH
treated implanted groups. This is consistent with pre-
vious work in cattle showing that minimal regulation
in CYP19A1 gene expression can contribute to meas-
urable differences in E2 synthesis [9,25]. Normal
follicular development relies on increasing concentra-
tions of E2 corresponding with follicle maturation and
resultant proliferation and differentiation of GC [26].
Additionally, elevated levels of E2 in culture medium
improves growth of oocytes from early antral follicles
[27] supporting an important role of E2 in folliculo-
genesis. However, elevated exogenous concentration
of E2 can increase the chance of developing cystic fol-
licles and decreases fertility in heifers [6].
In conclusion, these results indicate that follicles
which develop in the presence of high concentrations
of androgenic and estrogenic steroids via an implant
have an altered ability to respond to FSH stimulation
as demonstrated by varied steroidogenic enzyme ex-
pression and elevated estradiol production. Thus, ef-
forts should be made to avoid the use of implanted
heifers to study steroidogenesis in small follicle GC
culture systems.
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